A clue to the therapy of neurofibromatosis type 2: NF2/Merlin is a PAK1 inhibitor

Yumiko Hirokawa, Anjali Tikoo, John Huynh, Tamara Utermark, C. Oliver Hanemann, Marco Giovannini, Guang Hui Xiao, Joseph R. Testa, John Wood, Hiroshi Maruta*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)20-26
Number of pages6
JournalCANCER JOURNAL
Volume10
Issue number1
DOIs
Publication statusPublished - 2004

Cite this